|
MSHP – Heartland & MPhA Joint Virtual Continuing Education Event
|
|
« Go to Upcoming Event List
|
|
|
Join MSHP - Heartland & MPhA for the Central Minnesota Pharmacy Resident Clinical Pearls 2023 virtual continuing education event.
This event is approved for MN Board of Pharmacist CE Credit (1.5 hours) through the Heartland Chapter of MSHP.
Registration & Event Details Registration:
This event is free but registration is required. Please click here to register. Date:
Thursday, April 6, 2023
Schedule of Events:
3:00 - 3:05 pm: Welcome & Instructions
3:05 - 4:15 pm: Pearl Presentations
4:15 - 4:30 pm: Questions for Presenters Location:
The comfort of your office or home via Zoom
Presentations ByAndrea Mohr, PharmD – PGY1 – Essentia Health – St. Joseph’s Medical Center
Presentation Topic: Tamoxifen in the Treatment of Bipolar Disorder
Discuss the utility of tamoxifen for the treatment of bipolar disorder
Amanda Schaper, PharmD – PGY1 – Essentia Health – St. Joseph’s Medical Center
Presentation Topic: Sodium Nitrite Poisoning
Develop a treatment plan for sodium nitrite poisoning when presented with a patient case.
Kwon Park, PharmD – PGY1 – U of M – St. Cloud Centracare
Presentation Topic: Perioperative Management of Warfarin and Bridging
Evaluate evidence to determine whether to bridge patients on warfarin for elective procedures
Erin Salo, PharmD – PGY1 – U of M – Paynesville CentraCare
Presentation Topic: Management of Antiphospholipid Syndrome
Discuss the safety and efficacy of direct oral anticoagulants vs vitamin K antagonists for antiphospholipid syndrome
Annie Wenzel, PharmD – PGY1 – U of M – Cash Wise Clinic Pharmacy / Wilmar – CentraCare
Presentation Topic: Mounjaro: A new dual acting therapy to treat type II diabetes
Examine the place of Mounjaro (tirzepatide) in the 2023 Standards of Care in Diabetes Guideline
Rebecca Sauter, PharmD – PGY1 – U of M – St Cloud VA
Presentation Topic: Low-Dose Naltrexone for Pain
Evaluate the evidence and clinical use of low dose naltrexone for pain
Aaron Johnston, PharmD – PGY1 – CentraCare - St. Cloud Hospital
Presentation Topic: Don’t get Tripped up on Cyclic Vomiting – The Use of Sumatriptan for Cannabinoid Hyperemesis Syndrome
Justify the use of sumatriptan for cannabinoid hyperemesis syndrome
Gabrielle Coudron, PharmD – PGY1 – CentraCare - St. Cloud Hospital
Presentation Topic: Are they Toxic? The Risk of Serotonin Syndrome for Linezolid Used in Combination with Methadone or Buprenorphine
Given a patient case, categorize the risk of serotonin syndrome with the combination of linezolid and buprenorphine
|
|
|
Print Page